Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection

NCT02901717 is registered in ClinicalTrials.gov with Leonard-Meron Biosciences, Inc. as lead sponsor.

NCT NCT02901717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02901717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection
Lead sponsor
Leonard-Meron Biosciences, Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
February 13, 2018
Completion date
March 31, 2023
Enrollment
144 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

catheter-related infections